FSP Advocacy Update - March 3, 2025

Those of you who attended the very successful FSP convention in Orlando several weeks ago, were informed of the threat of legislation proffered by another physician specialty which initially would have adversely affected the financial viability of many of our pathology practices.  This has been a battle we have fought for decades against the insurance industry, but never against another professional medical Society. Furthermore, this legislation would have potentially dictated pathology billing practices, procedures, codes and/or fee amounts. Your FSP Leadership team along with CAP leadership and advocacy staff spent many hours in virtual meetings with the Florida Academy of Dermatology without satisfaction that we could resolve our differences. Thankfully, through our work with the Florida Legislature and continued negotiations between our lobbyist and those representing dermatology,  we are grateful to share that the Academy withdrew their efforts before the 2025 Legislative Session was set to convene on March 4th. The FSP extends sincere gratitude to our lobbyist, Amy Young for her tireless efforts and unwavering support as well as Steve Weinstein our legal counsel and our trusted partner David Smith at MedReceivables Advisor. In addition, we would like to thank CAP leadership and CAP advocacy staff for participating in the discussions and for their guidance and support on this issue. 
 
Additionally, we thank our FSP members and conference attendees for their generosity and commitment. Together, we raised $8,500 for the FSP Pathology PAC during the most recent FSP conference. We encourage all members to make their annual contribution to the FSP Pathology PAC by visiting https://flpath.org/advocacy/political-committee.

Your support is essential in protecting and advancing the interests of pathologist in Florida, helping us influence policies that protect and advance the interests of pathologists, build relationships with legislators to ensure they understand the value of pathology in healthcare, and defend ourselves against harmful legislation that could negatively impact pathology practices, billing, reimbursement, and ultimately patient care.